carmustine has been researched along with Erythema in 3 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Erythema: Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lane, N | 1 |
| Donaldson, MR | 1 |
| Stetson, CL | 1 |
| Smith, JL | 1 |
| Peck, GL | 1 |
| Frost, P | 1 |
| DeVita, VT | 1 |
3 other studies available for carmustine and Erythema
| Article | Year |
|---|---|
JAAD grand rounds quiz*: Dusky intertriginous plaques and acral erythema after bone marrow transplant.
Topics: Adult; Antineoplastic Agents; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Erythema; E | 2010 |
Hypertrophic scar after cryotherapy and topical tretinoin.
Topics: Administration, Topical; Carcinoma, Basal Cell; Carmustine; Cicatrix; Connective Tissue; Cryosurgery | 1973 |
Pigmentation due to a new antitumor agent. Effects of topical application of BCNU [1,3-bis(2-chloroethyl)-1-nitrosourea].
Topics: Administration, Topical; Antineoplastic Agents; Carmustine; Dihydroxyphenylalanine; Erythema; Humans | 1966 |